|
|
Volumn 12, Issue 5, 1997, Pages 876-878
|
|
Vascular access thrombosis--what are the possibilities of intervention?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLCYSTEINYLASPARAGINYL 5,5 DIMETHYLTHIOPROLYL 4 AMINOMETHYLPHENYLALANYLGLYCYLASPARTYLCYSTEINE;
ACETYLSALICYLIC ACID;
ACTIVATED PROTEIN C;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
ARL 66096;
CLOPIDOGREL;
CYTOKINE;
FIBRINOGEN RECEPTOR ANTAGONIST;
LOTRAFIBAN;
PENTAMIDINE;
POLITEF;
PURINERGIC RECEPTOR BLOCKING AGENT;
SEROTONIN;
TICLOPIDINE;
UNCLASSIFIED DRUG;
ARTERIOVENOUS FISTULA;
ARTERIOVENOUS SHUNT;
BLEEDING;
DIARRHEA;
EDITORIAL;
GASTROINTESTINAL SYMPTOM;
HEMODIALYSIS;
HIGH RISK PATIENT;
HUMAN;
NAUSEA;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
POINT MUTATION;
PRIORITY JOURNAL;
RASH;
THROMBOCYTE ACTIVATION;
VASCULAR ACCESS;
VASCULAR ENDOTHELIUM;
VEIN THROMBOSIS;
ANTICOAGULANTS;
CATHETERS, INDWELLING;
CYTOKINES;
HEMOSTASIS;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
RENAL DIALYSIS;
RISK FACTORS;
SEROTONIN;
THROMBOSIS;
|
|
EID: 0030913799
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/12.5.876 Document Type: Editorial |
|
Times cited : (10)
|
|
References (11)
|
